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Stefanie Seyring, Jacqueline Gürke, Elisa Haucke, Julia Miriam Knelangen,
Bernd Fischer, and Anne Navarrete Santos
Department of Anatomy and Cell Biology (M.S., M.P., S.S., J.G., E.H., J.M.K., B.F., An.N.S.) and
Department of Cardiothoracic Surgery (Al.N.S.), Faculty of Medicine, Martin Luther University, 06097
Halle (Saale), Germany; and Department of Obstetrics and Gynaecology (T.P.), University Medical Center
Groningen, University of Groningen, 9712 CP Groningen, The Netherlands
According to the “developmental origin of health and disease” hypothesis, the metabolic set
points of glucose and lipid metabolism are determined prenatally. In the case of a diabetic preg-
nancy, the embryo is exposed to higher glucose and lipid concentrations as early as during pre-
implantation development. We used the rabbit to study the effect of maternal diabetes type 1 on
lipid accumulation and expression of lipogenic markers in preimplantation blastocysts. Accompa-
nied by elevated triglyceride and glucose levels in the maternal blood, embryos from diabetic
rabbits showed a massive intracellular lipid accumulation and increased expression of fatty acid
transporter 4, fatty acid–binding protein 4, perilipin/adipophilin, and maturation of sterol-regu-
lated element binding protein. However, expression of fatty acid synthase, a key enzyme for de
novo synthesis of fatty acids, was not altered in vivo. During a short time in vitro culture of rabbit
blastocysts, the accumulation of lipid droplets and expression of lipogenic markers were directly
correlatedwith increasingglucose concentration, indicating thathyperglycemia leads to increased
lipogenesis in the preimplantation embryo. Our study shows the decisive effect of glucose as the
determining factor for fatty acid metabolism and intracellular lipid accumulation in preimplan-
tation embryos. (Endocrinology 155: 1498–1509, 2014)
The global rise in the prevalence of diabetes mellitus isparalleled by analarming increase in diabetic pregnant
women.Currently, in thewesternworld3%to10%ofpreg-
nancies are affected (1). Diabetes mellitus is associated with
abnormalities in lipidmetabolism such as hypertriglyceride-
mia and low levels of high-density lipoprotein (2).Maternal
metabolicdisorders arewell knownrisk factors affecting fer-
tility and embryonic and fetal development.
Early embryos are able to store intracellular lipids in the
form of lipid droplets (3). Lipids play an important role in
energy metabolism during early embryo development by
serving as an energy source and influencing properties and
functions of biological membranes, cell-cell interactions,
cell proliferation, and intercellular and intracellular trans-
port (for a review, seeRef. 4). The size and number of lipid
droplets are considered as markers of embryo vitality (5,
6). Embryos cultured with serum abnormally accumulate
cytoplasmic lipids, probably as a result of incorporationof
lipoproteins from the serum (6–8). An increased amount
of intracellular lipids reflects poor embryo quality and
developmental potential. Pig and bovine embryos contain
the highest amounts of lipids. This observation correlates
with the lowest survival rate after cryopreservation (9–
12). Mouse embryos with low amounts of lipid droplets
are not as sensitive toward adverse effects of vitrification
as embryos from other species (13).
Lipid droplets are coated by lipid droplet–associated pro-
teins (PLIN1–4). They regulate the assembly, maintenance,
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and composition of lipid droplets, as well as lipolysis and
lipid efflux (14–16). The best known are perilipin and adi-
pophilin, also referred as PLIN1 and PLIN2. Adipophilin
expression has been documented previously fromday 2post
coitum (pc) onward in rabbit preimplantation embryos (17).
The first step in long-chain fatty acid utilization is their
uptake across plasmamembranes. This process involves 2
components, passive diffusion through the lipid bilayer
andprotein-facilitated transfer. In early embryos, the fatty
acid uptake is poorly understood. However, a facilitated
transport is possible, as indicated by the expression of
fatty acid transport protein (FATP) 4 and fatty acid–bind-
ing protein (FABP) 4 in mouse blastocysts (18) and in
human trophoblast cells (19, 20).
The expression levels of FATP4 correlate with measures
of obesity and insulin resistance (21). FABP4, also known as
adipocytefattyacid–bindingprotein(AFABP)oraP2,affects
intracellular lipid metabolism by transporting fatty acids to
the nucleus for transcriptional regulation, to mitochondria
for -oxidation, and to lipid droplets for storage (22, 23).
Newevidence frompopulation studies andexperimental an-
imal models indicates that serum FABP4 is a powerful new
risk marker for predicting obesity, insulin resistance, and
dyslipidemia (24, 25). However, the exact secretion mecha-
nism of FABP4 is still not clear.
A source of intracellular fatty acids is de novo synthesis.
Fatty acid synthase (FASN), the key enzyme in de novo
lipogenesis, coordinates togetherwithacetyl-CoAcarbox-
ylase energy homeostasis by converting excess food intake
into lipids for storage (26, 27). FASN/ nullmutantmice
die during preimplantation development, demonstrating
the importantroleduringearlyembryonicdevelopment(28).
The promoter region of FASN contains binding sites for the
transcription factor sterol-regulated elementbindingprotein
(SREBP) 1 (29). SREBPs are synthesized as precursor pro-
teins that remain bound to the endoplasmic reticulum.After
activation, SREBP is processed and translocated to the nu-
cleus (30, 31). The mature nuclear SREBP activates the tran-
scriptionofgenes regulatingsynthesisanduptakeof fattyacids,
triglyceride, and cholesterol (31, 32). Currently, 3 different
isoforms have been described: SREBP1a and SREBP1c, de-
rived from a single gene by alternative transcription start
sites, and SREBP2 (33). SREBP-overexpressing transgenic
animals showed an accumulation of cholesterol and/or fatty
acids in liver cells (32, 34, 35), indicating that the SREBP1
isoforms are more directed forward activation of fatty acid
biosynthesis, whereas SREBP-2 is more specific for control-
ling cholesterol biosynthesis.
Despite the increasing incidence ofmetabolic disorders in
womenof reproductive age, fewattemptshave tobemade to
analyze the maternal influence on embryonic lipid metabo-
lism (36–38). Therefore, we have investigated intracellular
lipid accumulation and expression of key lipogenic markers
(such as perilipin, adipophilin, FATP4, FABP4, FASN, and
SREBP1) in response to hyperglycemia in vivo caused by an
inducedmaternaldiabetesmellitus type1andhyperglycemia
created in vitro in rabbit preimplantation embryos.
Materials and Methods
Alloxan treatment
Experimental insulin-dependent diabetes (expIDD) was in-
duced inmature 18- to 20-week-old female nonpregnant rabbits
by alloxan treatment (Sigma-Aldrich) as described before (39).
Rabbits were held in the diabetic condition with permanent
blood glucose concentrations of14 mmol/L by regular insulin
supplementation 4 times/d (Insuman Rapid and Lantus; sanofi
aventis), started on the second day after alloxan treatment. The
blood glucose level was monitored with a MediSense Precision
Xceed Diabetes Management System (Abbott) 2 times/d. For
that, fresh bloodwas collected at 10:00 AM and 6:00 PM by punc-
turing the vena auricularis lateralis and tested for glucose con-
centration by a commercial test strip.
All animal experiments were conducted in accordance with
the principles of laboratory animal care, and the experimental
protocol hadbeenapprovedby the local ethics commissionof the
Landesverwaltungsamt Dessau (reference no. 42502-2-812).
Embryo recovery
Embryos were collected from sexually mature rabbits stim-
ulated with 110 IU of pregnant mare serum gonadotropin sc
(Intervet) 3 days before mating. After mating, 75 IU of human
chorionic gonadotropin was injected iv (Intervet). Mating and
embryo recovery were performed as described previously (40).
Ondays3,4, and6pc embryoswere flushed fromoviductsoruteri,
respectively,washed3timeswithPBSandrandomlydividedamong
the experimental groups. On day 6 pc, gastrulation stages can be
reliably discriminated in the rabbit because implantation starts on
day 6 18 hours, ie, half a day later (41). Only blastocysts from
gastrulation stage 1 and 2 were used for further analyses.
Embryo in vitro culture
To study the effects of different glucose concentrations on
perilipin/adipophilin, FABP4, FATP4, andFASNexpressionand
intracellular lipid accumulation, day 6 blastocysts were cultured
in groups of 6 to 10 at 37°C in a water-saturated atmosphere of
5% O2, 5% CO2, and 90%N2. Blastocysts were cultured for 6
hours in serum- and insulin-free BSM II medium (42) with 0, 10
(standard culture medium), and 25 mM glucose (hyperglycemic
conditions), respectively.
Quantification of triglycerides in blood samples
Triglyceride concentrations in blood samples were measured
by a commercial kit (DiaSys Triglycerides FS; Diagnostic Sys-
tems). All procedures were performed according to the manu-
facturer’s instructions. To measure the serum triglyceride con-
centration, blood samples were collected with the S-Monovette
system(Sarstedt), left to coagulate for at least 30 minutes, and
centrifuged for 10minutes at 4°Cand1000 g. The supernatant
was stored at 80°C until use.
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Oil Red O staining of rabbit blastocysts
Blastocystswerewashed twice in ice-coldPBSand fixed in4%
(wt/vol) paraformaldehyde for 10 min. The fixed blastocysts
were washed again in ice-cold PBS and transferred to 0.05%
(wt/vol) polyvinyl alcohol (PVA)/PBS. Blastocyst coverings were
removed mechanically. The embryonic disk was mechanically dis-
sectedwithsurgical forcepsandscissors (FineScienceToolsGmbH)
(39) and used immediately forOil RedO staining.Oil RedO stock
solution (0.5mgofRedOilO [Sigma-Aldrich] dissolved in 100mL
of isopropanol)was diluted 3:2with distilledwater. To remove the
precipitate, the working solution was filtered using a filter with a
pore diameter of 20 m (BD Biosciences).
For Oil Red O staining, the embryonic disc was incubated in
filtered Oil Red O solution for 2 hours. After staining the lipid
droplets, theOil RedO staining solutionwas removed bywashing
the embryonic disc for 3 hours in 0.05% (wt/vol) PVA/PBS. Sub-
sequently, the embryonic disk was embedded on Superfrost slides
(Menzel Gläser) using 4.8 g ofMowiol reagent (Calbiochem, Ger-
many) dissolved in 12.0 g of glycerol (Merck). Embryonic disks
were examined by light microscopy (BZ 8000; Keyence).
Preparation of a single-cell suspension
For the separation of blastocysts to single-cell suspensions,
the gentleMACS-m-neural-tissue kit (Neural Tissue Dissocia-
tion Kit; Miltenyi Biotec) was used. Blastocyst coverings were
removed mechanically, and blastocysts were transferred in a
1.5-mL tube. The preheated papain enzymemix 1 providedwith
the kit was given directly to the blastocysts and incubated ac-
cording to the manufacturer’s protocol, except that the incuba-
tion step was performed at room temperature. Enzyme mix 2,
prepared according to the manufacturer’s protocol, was added
directly to the sample. The specimen was incubated for 15 min-
utes at room temperature on a rotator.
To remove cell aggregates from the cell suspension, a pre-
separation filter with a pore diameter of 40m (BDBiosciences)
was used. After a washing step, the cells were resuspended in
ice-cold 0.05% (wt/vol) PVA/PBS. Nile Red stock solution (100
g/mL; Sigma-Aldrich) was prepared in dimethyl sulfoxide and
stored in the dark. For Nile Red staining, the dye was added at
a final concentrationof 0.1g/mL.The cellswere then incubated
on ice for 5 minutes, centrifuged, and washed with 0.05% (wt/
vol) PVA/PBS. Afterward they were resuspended in a volume of
0.05% (wt/vol) PVA/PBS and kept on ice in the dark until flow
cytometry analysis.
Flow cytometry
All measurements were performed on a BD FACS Vantage
(BDBiosciences) equippedwith 3 lasers (excitationwavelengths:
488, 633, and 351nm) as described previously (43). Cell debris,
doublets, and aggregates were excluded from analysis. Blastocyst
cells withoutNile red staining served as a negative control for flow
cytometry analysis. Measurements and data analysis were per-
formed with FACSDiva (version 5.0.3; BD Biosciences). Nile Red
specifically stains intracellular lipiddroplets, excites at485nm,and
emits at 525 nm. For sorting, a 90-m nozzle was used, and the
sorting rate was no more than 1000 events per second.
The visualization by dot plot and histogram shows 2 different
cell populations R1 (P1) and R2 (P2). To prove that region R1
contains embryoblast and R2 contains trophoblast cells, we
sorted both cell populations and used them subsequently for
RT-quantitative PCR (qPCR) analyses for cytokeratin 18 and
cdx2, 2 trophoblastmarkers (44).Cytokeratin 18 and cdx2were
highly expressed in the R2 cell population, demonstrating that
these cells were almost exclusively trophoblast cells (Figure 1I).
The analysis of the percentage of cells located in R3 (cell
debris or putative dead cells) revealed no significant differences
between the normohyperglycemic and hyperglycemic groups.
This result suggests that in our experiments increased cell death
in the hyperglycemic group compared with that in the control
group can be excluded.
RNA isolation and cDNA synthesis
mRNA of single blastocysts was extracted with Dynabeads
oligo(dT)25 (Invitrogen) and subsequently used for cDNA syn-
thesis. All protocol procedures were performed according to the
manufacturer’s instructions, with modifications described pre-
viously (45).
RT-PCR
RT-PCR amplification was performed with 0.5 L of cDNA
from single blastocysts in a 25-L volume containing 200 M
concentrations of each dNTP, 2.5 U of Taq polymerases, and
specificoligonucleotides for adipophilin, FABP4,FATP4,FASN,
and glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
(primers are listed in Supplemental Table 1 published on The
Endocrine Society’s Journals Online web site at http://end.
endojournals.org). The nucleotide sequence for rabbit FASN
was determined using human primers for amplification of rabbit
liver cDNA.The amplificationwas done for 40 cycles (94°C for 45
seconds, 60°C for 45 seconds, and 72°C for 60 seconds). The re-
sulting PCR products were separated by electrophoresis on 2%
agarosegels andstainedwithethidiumbromide.ThePCRproducts
were sequenced and analyzed as described previously (46). Se-
quence homology was proven by using the alignment BLASTN
tool.
RT-qPCR
Amounts of FAS, FATP4, FABP4, adipophilin, and GAPDH
cDNA were determined by real-time qPCR with SYBR Green
detection by using the StepOnePlus System (Applied Biosystems)
with a no template control for each primer set (described in Ref.
47). The nucleotide sequences of the primers used in this study are
listed in Supplemental Table 1. The amount of cDNA per sample
was normalized by referring to the GAPDH gene. GAPDH was
shown to be unaffected by the treatment because no variation was
observed between the absolute GAPDH levels and GAPDH RNA
levels inblastocysts fromhealthy rabbits (47). qPCRs for target and
reference genes were always run in duplicate from the same cDNA
dilution taken from the same RT reaction.
The absolute amount of the transcripts was calculated along
with a standard (calibrator) sample. As standards we used de-
fined concentrations of plasmid standards constructed for the
gene of interest and GAPDH. For all genes investigated a partial
sequence was amplified from rabbit tissues. Purified PCR prod-
ucts were ligated into pGEM-Twith subsequent transformation
in XL1Blue competent bacteria (described in Ref. 47).
Results are given in molecules of the target gene per GAPDH
molecule. Statistical analysis was performed on the amounts of
molecules. Fold changes were calculated when the results are
expressed as percentages.
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Protein preparation and immunoblotting
Protein preparation, quantification, and Western blotting
were performed with 8 to 10 blastocysts as described previously
(48). ForWestern blot analysis, 25gof total protein lysateswas
subjected to SDS-polyacrylamide electrophoresis and electro-
transferred to nitrocellulosemembranes. For detection of FASN,
SREBP1, and -actin, membranes were blocked in Tris-buffered
saline containing 0.1% (vol/vol) Triton X-100 (0.1% TBST)
with 3% (wt/vol) nonfat dry milk at room temperature for at
least 1 hour. For perilipin detection,membraneswere blocked in
0.1% TBST with 3% (wt/vol) BSA for 2 hours. The primary
antibody was incubated at 4°C overnight. The following anti-
bodies were used as follows perilipin (1:1000; Sigma-Aldrich),
FASN (1:1000; Santa Cruz Biotechnology), SREBP1 (1:1000;
Active Motif), -actin (1:40 000; Sigma-Aldrich), anti-rabbit
IgG conjugated to horseradish peroxidase (HRP) (1:15 000;
DAKO Cytomation), and anti-mouse IgG conjugated to HRP
(1:45 000; Dianova). The protein amount was calculated as the
ratio of band intensities (perilipin protein or FASN protein vs
-actin protein, respectively) in the same blot to correct for dif-
ferences in protein loading.
Immunohistochemical localization of FABP4 and FASN
Blastocystswerewashed twice in ice-coldPBSand fixed in4%
(wt/vol) paraformaldehyde at 4°C overnight. The sample was
prepared, and the immunohistochemical protocol was per-
formed as described previously (48). Antibodies for FABP4 and
FASN (both Santa Cruz Technology) were diluted 1:100 and
1:500 in 3% (wt/vol) BSA/PBS, respectively. The secondary an-
tibody Dako EnVision System HRP-labeled polymer anti-
mouse (1:1 in PBS) and diaminobenzidine (WAK-Chemie
Medikal) were used for detection.
All steps were performed within the same experiment, and
sampleswere examinedmicroscopically during the same session,
using identical microscope and camera settings (BZ 8000;
Keyence).
FABP4 ELISA
FABP4 concentrations in blastocyst fluids were measured by
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Figure 1. Oil Red O staining and Nile Red flow cytometry analyses of blastocyst cells from diabetic rabbits. A, Blastocysts derived from healthy and
diabetic (expIDD) rabbits were stained with Oil Red O, marking intracellular lipid droplets red in trophoblast (TB) and embryoblast (EB) cells (scale
bar corresponds to 50 m). Nuclei were counterstained with hematoxylin in blue. B–G, For flow cytometry analysis blastocyst cells were stained
with Nile Red. A representative analysis is shown. Blastocyst cells were visualized on a dot plot of forward scatter (FSC) vs side scatter (SSC) (B, D,
and F) or in a Nile Red histogram (C, E, and G). The visualization by dot plot, using the parameters granularity and cell size, indicated 2 different
cell populations, region R1 with embryoblast cells and R2 with trophoblast cells, respectively. For further analyses, blastocyst cells were gated in
region R1 and R2. Cell debris and death cells were excluded (region R3). Blastocyst cells were gated in region R1 and R2 from normoglycemic (D)
and diabetic (F) rabbits. Nile Red absorbance of blastocyst cells from regions R1 and R2 is shown for normoglycemic (E) and for diabetic (G) rabbits
in P1 and P2, respectively. H, Nile Red mean fluorescence in R2 (P2) of normoglycemic and diabetic cells determined in 3 independent experiments
is shown. Blastocyst cells were sorted in region R1 and R2 and subsequently used for RT-qPCR analysis of trophoblast markers cdx2 and
cytokeratin18. I, Results are shown as relative amounts and fold change of R1 (means  SEM; N  4, n  18). R2 sorted cells were identified as
trophoblast cells with 10- and 5-fold higher cdx2 and cytokeratin 18 RNA amounts, respectively, than those in the R1 cells.
Table 1. Mean Nile Red Fluorescence Intensity From
Normoglycemic and Diabetic (expIDD) Blastocyst Cells in
Region R1 (P1) and Region R2 (P2)
Nile Red
(Mean  SEM) P Value
R1 (P1) normoglycemic 951  280 .6
R1 (P1) expIDD 1093  202
R2 (P2) normoglycemic 1566  267 .03
R2 (P2) expIDD 2503  233
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according to the manufacturer’s instructions. Flushed blasto-
cystswerewashed2 timeswith ice-coldPBS.Blastocyst stage and
size were determined. Blastocysts were then placed on a dry
watch glass. Extracellular coverings were removed mechani-
cally, blastocysts were punctured, and the effluent cavity fluid
was collected. Blastocyst fluids were stored at 80°C until use.
FABP4 concentrations were quantified in duplicate and com-
pared with an internal FABP4 standard (0.625–50 ng/mL).
Statistics
All data are expressed asmeans SEM.Levels of significance
between groups were calculated by factorial ANOVAwith Bon-
ferroni adjustment. A value of P  .05 was considered statisti-
cally significant.All experimentswere conducted at least 3 times.
Results
In previous studies, we demonstrated
that the increases in maternal blood
glucose concentrations correlate with
increased glucose levels in the uterine
secretions (39). Here, we focused on
the lipid content and lipogenic
markers to test whether a diabetic
disorder during early pregnancy
would affect the embryonic fatty
acid metabolism.
Elevated triglyceride levels in
female rabbits with expIDD at
day 6 pc
In blood samples of diabetic (ex-
pIDD) pregnant rabbits, triglyceride
levels were increased approximately
6-fold (3.55  0.43 mM; mean 
SEM) compared with that in the
healthy controls (0.57  0.05 mM)
[number of independent experiments
used for blastocysts (N)  3; total
number of blastocysts used for analy-
sis (n) 9; P .001], respectively.
Accumulation of intracellular
lipid droplets in normoglycemic
and diabetic (expIDD)
blastocysts
The effect of alloxan-inducedma-
ternal diabetes mellitus type 1 on in-
tracellular lipid accumulation was
examined by Oil Red O staining.
Blastocysts from diabetic rabbits
showed a higher accumulation of in-
tracellular lipids in the embryoblast
and trophoblast, indicated by the
higher amount of red-stained lipid
droplets (Figure 1A). To further sup-
port these data, we used a quantitative method to deter-
mine the cellular lipid content based on Nile Red staining
and flow cytometry analyses. In Figure 1, B to G, the re-
sults of a representative flow cytometry analysis are illus-
trated. Blastocyst cells were visualized by dot plot and
histogram. A higher Nile Red fluorescence intensity was
found in blastocyst cells from diabetic rabbits in both cell
populationsR1(P1)andR2(P2).However, incontrast tothe
R2 (Figure 1I and Table 1), the difference in the Nile Red
fluorescence mean in the R1 between normoglycemic and
diabetic blastocysts was not significant (data not shown).
The mean Nile Red absorbance is given in Table 1.
GAPDH  
Adipophilin 
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Figure 2. Expression patterns of the lipogenic markers adipophilin, FATP4, FABP4, and FASN in
rabbit preimplantation embryos. A, RT-PCR was performed with specific primers for adipophilin,
FATP4, FABP4, and FASN on rabbit morulae at day (d) 3, on blastocysts at days 4, 5, 6, and 8 pc,
and on 6-day-old blastocysts of different gastrulation stages with stage (st) 0, 1, 2, and 3.
Transcripts of adipophilin, FATP4, and FASN were detected in all analyzed developmental stages.
FABP4 transcription was measurable from gastrulation stage 1 (st 1) onward. A probe without
cDNA was used as negative control (ntc). As a positive control, a liver cDNA probe was used ().
The internal control was the expression of GAPDH in all probes. The FABP4 and FASN proteins
were detected by immunohistochemical analysis and visualized by a peroxidase-diaminobenzidine
reaction (brown color) (scale bar corresponds to 50 m). B, In blastocysts from healthy controls
(normoglycemic), FABP4 was localized in the cytosol and nucleus of embryoblast cells (EB). The
trophoblast cells (TB) were not or less stained for FABP4. In blastocysts from diabetic rabbits
(expIDD), the embryoblast and trophoblast cells showed more intense staining for FABP4,
especially in the nuclei of both cell lineages. Nuclei were counterstained in blue with
hematoxylin. C, Immunohistochemical localization revealed FASN in the cytosol of embryoblast
and trophoblast cells. No difference in staining and localization was found between blastocysts
from diabetic and normoglycemic rabbits. D, FABP4 concentrations were analyzed by ELISA in
blastocyst fluids of single blastocysts from normoglycemic and expIDD rabbits (means  SEM;
N  3; n  9; *, P  .05).
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Adipophilin and perilipin expression in
preimplantation embryos from diabetic rabbits
Intracellular lipiddroplets are coatedby the lipiddroplet–
associated proteins perilipin and adipophilin. The transcrip-
tion of adipophilin was detectable in the rabbit preimplan-
tation embryos from day 3 old morulae onward in all
analyzed days and stages (Figure 2A). Transcription levels in
blastocysts (day6pc stage1) fromdiabetic rabbits (expIDD)
were significantly increased compared with those from nor-
moglycemic rabbits (Table 2).Quantification of adipophilin
in theembryoblastandtrophoblast revealed that the increase
in the adipophilin amount resulted from transcriptional up-
regulation,mainly inembryoblastcells (Table4). Inaddition,
the perilipin protein amount was significantly increased in
blastocysts from diabetic rabbits (Table 3).
FATP4 and FABP4 expression in preimplantation
embryos from diabetic rabbits
FATP4 and FABP4 are expressed in rabbit blastocysts.
Whereas FATP4 transcription was detectable in all inves-
tigated embryonic stages, starting on day 3 pc (Figure 2A),
FABP4 expression was only measurable in expanded and
gastrulating blastocysts on day 6 pc, from stage 1 onward
and on day 8 pc (Figure 2A). Analysis of FABP4 transcrip-
tion, however, revealed a cell lineage–specific FABP4 dis-
tribution pattern with the main expression in the embryo-
blast (Figure 2B). Only a few cells stained positive for
FABP4 in the trophoblast.
In diabetic conditions, the transcription levels for both
FATP4andFABP4were increased inblastocysts (Table2).
FATP4 mRNAwas increased in the embryoblast and tro-
phoblast (Table 4). For FABP4, the RNA amount was
increased only in the embryoblast (Table 4). Compared
with embryos from healthy rabbits, blastocysts from di-
abetic mothers showed more intense FABP4 staining in
both cell lineages, with themost prominent localization in
the nuclei (Figure 2B).
Because FABP4 canbe secreted fromcells and is present
in the circulation,weanalyzed theFABP4concentration in
blastocyst fluid. Analysis by ELISA showed that FABP4 is
present in blastocyst fluid and that the amount is increased
in the cavity fluid from diabetic blastocysts (Figure 2D).
FASN expression in preimplantation embryos from
diabetic rabbits
The key enzyme of de novo lipogenesis, FASN, was
detectable form day 3 old morulae (d3) onward in all an-
alyzed stages (Figure 2A). Neither FASN transcription
(Table 2) nor protein (Table 3) amountswere significantly
different in blastocysts from diabetic rabbits. In addition,
no alterations of FASN transcription levels in embryo-
blasts and trophoblasts from normoglycemic and diabetic
rabbits were detectable. However, a cell lineage–specific
transcription was observed (Table 4), with higher tran-
scripts in the embryoblast. FASN protein was localized in
bothembryoblast and trophoblast cellswithacytoplasmic
localization (Figure 2C). In blastocysts from diabetic rab-
bits, no differences in staining intensity or in cellular lo-
calization were observed.
SREBP1 expression in preimplantation embryos
from diabetic rabbits
Under hyperglycemic conditions, no changes in total
SREBP1 protein amounts were observed (Table 2). How-
ever, the ratio of cytoplasmic (cSREBP1) and mature, nu-
clear SREBP1 (nSREBP1) was influenced. Blastocysts
from diabetic rabbits had relatively more SREBP1 located
in the nucleus (based on the total SREBP1 protein amount
and the ratio of nSREBP1 to cSREBP1) compared with
that of blastocysts from normoglycemic rabbits (Table 2),
indicating a higher transcriptional regulation by SREBP1
in blastocysts from diabetic rabbits.
Table 2. Relative Protein Amount of Lipogenic Markers
in Blastocysts from Normoglycemic and Diabetic
(expIDD) Rabbits
Protein Normoglycemic expIDD P Value
Perilipin 100.0  3.5 136.8  10.5 .048
FASN 100.0  6.8 105.3  1.2 .473
nSREBP1 100.0  7.2 107.2  5.2 .437
cSREBP1 100.0  12.7 76.9  5.8 .138
Ratio: nSREB1/
cSREBP1
0.51  0.03 0.70  0.03 .005
Results are given relative to protein amounts in blastocysts from
healthy rabbits (normoglycemic) (means  SEM; N  3; n  10).
Table 3. Relative mRNA Amount of Lipogenic Target Genes in Blastocysts from Normoglycemic and Diabetic
(expIDD) Rabbits
mRNA Normoglycemic expIDD % P Value
Adipophilin 51.76  15.28 167.78  3.99 287.4  29.9 .020
FABP4 4.45  2.03 9.91  2.27 222.6  51.1 .041
FATP4 855.4  124.1 1382.4  179.6 188.9  23.2 .038
FASN 0.66  0.18 0.38  0.06 58.7  10.1 .195
Results are given as molecules and as a percentage of transcription levels in normoglycemic blastocysts (means  SEM; N  3; n  10).
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Glucose-dependent expression of lipogenic genes
To clarify whether glucose can regulate the expression
of lipogenic genes, we cultured blastocysts without glu-
cose (0mM) andwith 10mM (standard culture media) or
25 mM (hyperglycemia in vitro) for 6 hours in vitro. The
quantification of adipophilin and FABP4 transcript levels
and perilipin protein showed increased expression of all
markers in blastocysts cultured under hyperglycemic con-
ditions (Figure 3, A, B, C, and E). No significant differ-
ences were measured for the FATP4 transcript levels in
response to the various glucose concentrations (Figure
3D). In contrast to diabetic conditions in vivo, the FASN
protein amountwas increased in blastocysts culturedwith
10 and 25mMcomparedwith that in blastocysts cultured
with 0mM, respectively (Figure 3, F andG). Total protein
amounts of SREBP1 were increased in a glucose-depen-
dent manner with a higher accumulation of mature
nSREBP1 in the nucleus (Figure 3, H–K).
Glucose-dependent accumulation of lipid droplets
Excess energy intake leads to an accumulation of intra-
cellular lipids. To analyze whether a high concentration or
the lack of glucose influences the amount of lipid droplets in
embryos,we cultured blastocysts (day 6 pc) fromnormogly-
cemicanddiabetic rabbits for6hourswith either0,10,or25
mM glucose and afterward stained intracellular lipid drop-
lets with Oil RedO. Blastocyst cells from both normoglyce-
mic and diabetic (Figure 4) rabbits showed a glucose-depen-
dent accumulation of intracellular lipids. High glucose
concentrations led to a higher amount of lipid droplets com-
paredwith0and10mMinblastocysts fromnormoglycemic
rabbits. The lowest amount of lipid droplets was found in
blastocysts cultured with 0 mM. A comparable glucose-de-
pendent increase in lipiddropletswasobserved inblastocysts
fromdiabetic rabbits.However, the amountof lipiddroplets
in each group (0–25mM)was higher in diabetic blastocysts
than in the corresponding controls.
Discussion
Since the initial observation byMills in 1982 (49), a great
number of studies have shown the determining effect of
maternal hyperglycemia onpregnancy outcome, offspring
malformation, and the risk of later life diseases (39, 50–
55). Adverse effects of high glucose concentrations have
been shown by in vitro and in vivo culture experiments,
such as retarded embryo development and increased ap-
optosis (39, 55–63). The current study shows for the first
time the direct influence of maternal diabetes in vivo and
hyperglycemia in vitro on embryonic lipid storage. One
central finding of this study is the highly increased amount
of intracellular lipid droplets in blastocysts from diabetic
rabbits. Embryos with higher amounts of cytoplasmic lip-
ids aremore sensitive to chilling and cryopreservation (64)
andhavea lowerdevelopmental efficiency (10,11).There-
fore, the increased amount of lipid droplets in blastocysts
may contribute to the adverse effects of maternal diabetes
on preimplantation embryo development.
The massive lipid accumulation in blastocysts from di-
abetic rabbits raises the question of whether the embryo
produces lipids from excessmaternal glucose supply or by
an increased transport of fatty acids into the cell. Type 1
diabetes mellitus is not only characterized by high serum
glucose concentrations but also by increased serum tri-
glyceride concentrations. These phenomena are closely re-
flected by hyperglycemia and hypertriglyceridemia in the
diabetic rabbitmodel. Diabetesmellitus is associatedwith
maternal and fetal dyslipidemia, which manifests as high
plasma triglyceride concentrations, elevated concentra-
tions of nonesterified fatty acids, increased concentrations
of low-density lipoprotein cholesterol, and decreased lev-
els of high-density lipoprotein cholesterol (20, 65–68).An
increase in fatty acids enhances the formation of lipid
droplets and expression of adipophilin and FABP4 (20,
69–71). Therefore, it is likely that the diabetes-associated
hyperlipidemia is a potent regulator of embryonic lipid
metabolism. This view is supported by the observation
Table 4. Relative mRNA Amount of Lipogenic Target Genes in Embryoblast and Trophoblast From Normoglycemic
and Diabetic (expIDD) Rabbits
mRNA
Embryoblast Trophoblast
Normoglycemic expIDD Normoglycemic expIDD
Adipophilin 100.0  8.3 131.3  11.8a 118.1  6.6 125.1  17.7
FABP4 100.0  17.1 293.3  71.2a 14.0  3.5b 9.9  1.8b
FATP4 100.0  6.4 147.2  15.3a 92.8  10.4 148.6  15.1a
FASN 100.0  23.5 91.4  23.4 25.9  6.7b 15.8  2.3b
Results are given as a percentage of the amount in the embryoblast from healthy rabbits (normoglycemic) (means  SEM; N  3; n  10).
a Amount significantly different between control and expIDD (P  .05).
b Amount significantly different between embryoblast and trophoblast (P  .05).
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that both normoglycemic and diabetic blastocysts cultured
for 6 hours in vitro showed a lower amount of lipid droplets
than that of their in vivo counterparts, implying that meta-
bolic factors other than glucose might play a role, too. Fur-
thermore, FASN expression was not altered in blastocysts
fromdiabetic rabbits. Because lipogenesis encompasses fatty
acid and subsequent triglyceride synthesis, it is tempting to
speculate that the unchanged FASN expression in vivo is the
result of an increased lipid supplyby thediabeticmother and
the increased expression of FABP4 and FATP4 in their blas-
tocysts (Figure 5). On the other hand, it is also possible that
the 3-fold increase in glucose in uterine secretions (20) is not
high enough to regulate FASN expression. Finally, the in-
creasedFABP4amount in the cavity fluid fromdiabetic blas-
tocysts may play a pivotal role by trafficking free fatty acids
to blastocyst cells.
In our in vitro model, we can create a hyperglycemic sit-
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Figure 3. Relative expression of lipogenic genes in rabbit blastocysts cultured in vitro with 0, 10, or 25 mM glucose. A, In vitro culture of
blastocysts for 6 hours with 0, 10, or 25 mM glucose led to a significantly higher adipophilin transcription level in blastocysts of the 25 mM group
(*, P  .05). Blastocysts were cultured in groups of at least 5 blastocysts (N  3; n  5). mRNA levels were analyzed by RT-qPCR, and results are
shown as means  SEM (*, P  .05). B and C, Relative perilipin amounts after 6 hours of cultivation without or with 10 or 25 mM glucose were
analyzed by Western blotting with anti-perilipin antibody and set in relation to total -actin. A representative Western blot for perilipin is shown in
panel C. Results of 3 independent stimulation experiments (N  3, n  9; means  SEM) are shown in panel B. The group without glucose (0
mM) was set at 100%. D and E, RT-qPCR analysis of FATP4 (D) or FABP4 (E) after in vitro culture (for 6 hours) of blastocysts with 0, 10, or 25 mM
shows a distinctly different expression pattern. In vitro culture with 10 or 25 mM or without glucose was performed in groups of at least 5
blastocysts in each treatment and repeated in 3 independent replicates (N  3; n  5). Results are shown as means  SEM (*, P  .05). F and G,
FASN protein amount was analyzed by Western blot and the 0 mM group (control) was set at 100% (*, P  .05). Results (F) and a representative
Western blot (G) are shown. H–K, Relative SREBP1 amounts after 6 hours of cultivation without or with 10 or 25 mM glucose were analyzed by
Western blotting with anti-SREBP1 antibody, which specifically detects cSREBP1 (125 kDa) and nSREBP1 (68 kDa). Culture was performed in
groups of at least 5 blastocysts in each treatment and repeated in 3 independent replicates (N  3; n  5). H, Relative SREBP1 protein amounts
(nSREBP1 and cSREBP1) in relation to those in the 0 mM group, which was set at 100%. I, Ratio of nSREBP1 vs cSREBP1. J, Representative Western
blot for SREBP1.
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of an oversupply of glucose in vitro, the embryo shows a
glucose-dependent regulation of lipogenic marker genes, in-
cluding FASN (Figure 5). We interpret these findings as in-
creased de novo lipogenesis, the first step of lipogenesis.
However, FATP4 expression was not affected in vitro be-
cause the blastocysts were not supplied with lipids from the
outside. Glucose can stimulate de novo lipogenesis via sev-
eral mechanisms. First, glucose can be converted into lipids
for storage (72). Furthermore, embryos cultured with high
glucose concentrations show a slightly increased uptake of
palmitic acid and an enhanced uptake of arachidonic acid
(36). That high glucose and enhanced fatty acid uptake in-
creasetheaccumulationof lipiddropletshasalsobeenshown
in renal tubal epitheliumandpancreatic-cells (73–76).The
up-regulationofFASNwasSREBP1dependent (74–76).We
found a glucose-dependent accumulation of lipid droplets, a
higher nuclear SREBP1 amount in vitro and an increased
nSREBP1/cSREBP1 ratio in vivo.
Therefore, SREBP1 could belong to
the connecting link between glucose
and lipid storage in preimplantation
embryos.
Several studies clearly show that
glucose is a main source and key sig-
nal for SREBP1 induction and cleav-
age of SREBP1precursor protein in a
dose-dependent manner (77–79), as
shown by our in vitro experiments,
too. This effect is not due to osmotic
properties, because glucose could
not be replaced by the glucose ana-
logs 2-deoxyglucose or 3-O-methyl
glucopyranose (77, 79). SREBP1 ac-
tivity is necessary not only for full
induction of de novo fatty acid syn-
thesis but also for intracellular lipid
droplet accumulation by increasing
cholesterol biogenesis and activation of the low-density
lipoprotein receptor (80–82), leading to increased
lipogenesis.
The present results are particularly important with re-
spect to possible short- and long-term consequences of in
vitro biotechnologies such as assisted reproductive tech-
nologies, in which embryos are cultured for various times
with high glucose concentrations before transfer. Exper-
imental evidence suggests that culture conditions influ-
ence normal development and may contribute to prenatal
and/or postnatal disorders (83–86). We show for the first
time that high glucose concentrations in vitro lead to a
higher lipid accumulation and an elevated expression of
key lipogenic target genes, indicating that the glucose con-
centration is critical for metabolic set points of embryonic
cells. Embryonic cells adapt to changes in glucose concen-
tration in the surrounding milieu and may retain the in-
formation during later differentiation, as has been shown
in embryonic stem cells (87).
However, we cannot rule out the possibility that factors
other than hyperglycemia or hyperlipidemia may also influ-
ence intracellular lipid accumulation and lipogenic gene ex-
pression. Insulin and IGFs,which are known to be regulated
by diabetic developmental conditions (39, 47), are potent
regulatorsofFASNexpressionandenzymeactivity (88–90),
FABP4 expression (91, 92), and SREBP1 transcription and
maturation (78, 93, 94). Therefore, the altered insulin/IGF
systemand/orapotential interplaybetween insulin/IGFs,hy-
perlipidemia, and hyperglycemia has to be kept in mind,
when theunderlyingmechanismofaberrant embryonic lipid
storage in diabetic blastocysts is discussed.




Figure 4. Intracellular lipid accumulation in blastocysts cultured in vitro with 0, 10, and 25 mM
glucose. Six-day-old blastocysts were removed from healthy (normoglycemic) and diabetic
(expIDD) rabbits and cultured in vitro with 0, 10, or 25 mM glucose for 6 hours. Then lipid
droplets were stained red with Oil Red O (red dots). Nuclei were counterstained blue with
hematoxylin. Representative pictures from trophoblasts are shown (scale bar corresponds to 50
m). Culture was performed in groups of at least 4 blastocysts in each treatment and repeated in
3 independent replicates (N  3; n  4).
Figure 5. Schematic mechanism of intracellular lipid accumulation in
rabbit blastocysts in diabetic conditions in vivo and hyperglycemia in
vitro. In the preimplantation embryo, hyperglycemia leads to a
nonphysiological lipid accumulation with increased expression of the
adipogenic markers adipophilin, perilipin, FABP4, and SREBP1. In in
vivo and in vitro conditions, the embryonic gene regulation differed
only in FATP4 or FASN with increases in FATP4 in vivo and FASN in
vitro.
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In conclusion, maternal diabetes alters the concentra-
tion of a variety ofmaternal nutrients, which in turnmod-
ifies themetabolic uterine environment for the developing
embryo. Exposure to such an altered nutrient profile can
disrupt normal development or, less dramatically, change
embryonicmetabolism.We demonstrated that embryonic
lipid storage is altered under induced maternal diabetes
mellitus in the rabbit. Intracellular lipid accumulation and
expression of key genes for lipid storage (perilipin and adi-
pophilin), fatty acid transport, andmetabolism (FATP4 and
FABP4) and lipogenesis (SREBP1) are increased. This ef-
fect canbe explained inpart by the fact that hyperglycemia
in vitro increases the expression of lipogenic target genes
and the amount of intracellular lipid droplets. Because
preimplantation embryo development is one of the most
critical periods in an individual’s life, future health trajec-
toriesmay be (mis)programmedwith severe consequences
later in life.
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